| Literature DB >> 34024691 |
Abstract
In ongoing viral pandemic named as COVID-19 also Severe Acute Respiratory illness (SARI) or Flue Like illness (FLI) reported surging in many cities of India and many of the patients opted for traditional medicine, in spite of they have been given a option of contemporary line of treatment instructed by health authorities, they opted to take traditional indian medicine that is Ayurvedic medicine. Present case series is a same novel experience of early diagnosing and treating mid aged, morbid individuals who took only Ayurvedic treatment and could get out of the disease without any complications. This case series had 10 mid aged, morbid patients with maximum symptoms of COVID-19 disease and their hemogram and CRP was suggestive of moderate to severe type COVID-19/FLI/SARI. They were diagnosed by contemporary methods of pathology and treated with Ayurvedic classical medicines Tamra Sinduradi Yoga and Bhunimbadi Kwath for 20 days along with continuing the medicines for their ongoing morbidities. All 10 patients showed recoveries without any complications, they reduced their all symptoms, drastic reduction in their CRP and corrections in their hemograms were observed and also they showed any complications neither physically nor in their pathological tests. Hence it can be concluded that early diagnosis and treating it with Ayurvedic medicine can manage viral pandemic issue in a very successful way.Entities:
Keywords: Ayurveda; Bhunimbadi Kwath; COVID-19; CRP; CRP, Critical reactive protein; D Dimer, Fibrin degradation product; ESR, Erythrocyte sedimentation rate; HR CT, High resolution computerized tomography; IgG, Immunoglobulin G; IgM, Immunoglobulin M; LDH, Lactate dehydrogenase; NL Ratio; NLR, Neutrophiles to lymphocyte ratio; RT-PCR, Reverse transcription polymerase chain reaction; SpO2, Oxygen saturation; Tamra Sinduradi Yoga; WBC, White blood corpuscles
Year: 2021 PMID: 34024691 PMCID: PMC8136275 DOI: 10.1016/j.jaim.2021.03.002
Source DB: PubMed Journal: J Ayurveda Integr Med ISSN: 0975-9476
Common symptoms of COVID-19/Sari/FLI Patients found on day one before treatment.
| 01 | 06 | 07 | 08 | 010 | 015 | 032 | 037 | 041 | 044 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Age | 52, | 53, | 49, | 46, | 54, | 57, | 47, | 48, | 62, | 69, |
| Morbidity | DM, Bp | DM | DM | – | DM | DM | – | – | – | DM, BP |
| CRP Value mg/Lit | 90 | 64 | 99 | 80 | 23 | 31 | 121 | 24 | 50 | 38 |
| Lowest Spo 2% Reported during treatment | 91% | 93% | 94% | 92% | 95% | 88% | 92% | 91% | 92% | 85% |
| Severe | Severe | Severe | Severe | Mild | Moderate | Severe | Mild | Moderate | Moderate | |
| Fever | Y+ | Y+ | Y+ | Y++ | Y+ | Y+ | Y++ | Y+++ | Y++ | Y++ |
| Head ache | Y+ | N | Y++ | Y++ | Y++ | Y+ | Y+ | Y++ | Y+ | Y++ |
| Cough | Y+++ | Y+ | Y+++ | Y++ | Y+++ | Y+ | Y++ | Y+ | Y+ | Y++ |
| Body ache | N | Y+ | N | Y++ | Y+ | Y++ | Y++ | Y+++ | Y++ | Y+++ |
| Fatigue | Y+ | Y+ | Y+ | Y+++ | N | Y+ | Y++ | Y+++ | Y+ | Y+++ |
| Taste loss | N | N | Y+ | Y+ | N | N | Y+ | Y+ | N | Y+ |
| Smell loss | N | N | Y+ | N | N | N | N | N | N | N |
| Breathlessness | Y+ | N | Y+ | Y+ | N | Y++ | Y++ | Y+ | Y+ | Y+++ |
| Dyspepsia | Y+ | Y+ | Y++ | Y++ | Y+ | Y+++ | Y++ | Y+++ | Y+ | Y+++ |
Y- Yes, N- No, + mild, ++ moderate, +++ High/DM – Diabetes, Bp- Hypertensive/CRP- Critical reactive protein, Spo 2 is blood oxygen saturation.
After completion of treatment.
| 01 | 06 | 07 | 08 | 010 | 015 | 032 | 037 | 041 | 044 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Age | 52, | 53, | 49, | 46, | 54, | 57, | 47, | 48, | 62, | 69, |
| Morbidity | DM, Bp | DM | DM | – | DM | DM | – | – | – | DM, BP |
| 5 | 2.7 | 2.9 | 1.86 | 3.96 | 3.02 | 0.62 | 4.4 | 2.16 | 3.43 | |
| Spo 2 | 96% | 97% | 97% | 96% | 98% | 94% | 97% | 96% | 96% | 94% |
| Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | |
| Fever | N | N | N | N | N | N | N | N | N | N |
| Head ache | N | N | N | N | N | N | N | N | N | N |
| Cough | Y+ | N | Y+ | N | Y+ | N | N | N | N | N |
| Body ache | N | N | N | N | N | N | N | N | N | Y+ |
| Fatigue | N | N | N | N | N | N | N | N | Y+ | Y+ |
| Taste loss | N | N | N | N | N | N | N | N | N | N |
| Smell loss | N | N | N | N | N | N | N | N | N | N |
| Breathlessness | N | N | N | N | N | N | N | N | N | N |
| Dyspepsia | N | N | N | N | N | Y+ | N | Y+ | N | Y+ |
| – | 0.7 | 0.9 | – | 0.6 | 1.28 | 1.1 | 1.17 | 0.9 | 1.0 | |
| – | 16 | – | – | – | 37.5 | 34.0 | 26.5 | 24.7 | ||
| – | 14 | – | – | – | 39.2 | 37.5 | 33.5 | 24.9 | 37.1 | |
Y- Yes, N- No, + mild, ++ moderate, +++ High/DM – Diabetes, Bp- Hypertensive/CRP- Critical reactive protein, Spo 2 is blood oxygen saturation, AntiB- Antibodies.